IP Library › Granted Patent US 9,039,763
Granted Patent B2
US 9,039,763 · App. 14/166,328 · Granted May 26, 2015

Tissue marking implant

Inventor: John D. Corbitt, Jr. (Lake Worth, FL)
Assignee: SenoRx, Inc.
A61F2/12A61B2019/5408A61F2/0059A61F2/0077A61L27/18A61L27/56A61L27/58
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,039,763
App. No.
14/166,328
Granted
May 26, 2015
Kind
B2
Abstract

An implant for marking an area within a living body includes a matrix material and a marking material. The implant is formable to fit the shape and size of a cavity in the human body. The implant is configured to support tissue surrounding the cavity and to allow in-growth of fibrous tissue into and replace at least a portion of the matrix material.

Claims (21)

1. An implant for marking an area within a surgically formed cavity of a living body, comprising a matrix material and a marking material, the matrix material configured to be elastically compressible and formable to fit the shape and size of the surgically formed cavity in the living body, and configured to fill the cavity and support tissue surrounding the cavity and to allow in-growth of fibrous tissue into and replace at least a portion of the matrix material.

2. The implant of claim 1 , wherein the marking material is a dye, and the matrix material and the marking material are configured such that the marking material leaches into tissue surrounding the surgically formed cavity from the matrix material.

3. The implant of claim 1 , the marking material being contained within the matrix material.

4. The implant of claim 1 , comprising at least one substance selected from the group consisting of medicinal substances, therapeutic substances, and diagnostic substances.

5. The implant of claim 1 , comprising at least one substance selected from the group consisting of radiation materials, antibiotics, chemotherapies, cancer therapeutics, hemostatic materials, and hormone therapeutics.

6. The implant of claim 1 , wherein the matrix material is at least partially biosorbable.

7. The implant of claim 1 , the matrix material includes an outer shell containing both biosorbable material and nonabsorbable material.

8. The implant of claim 7 , wherein the outer shell is configured to form a skeletal outer shell after a resorption of the biosorbable material.

9. The implant of claim 7 , wherein the outer shell comprises compressed matrix material.

10. The implant of claim 1 , wherein the matrix material is self-expanding.

11. An implant for insertion into a cavity of a living body, comprising:

a matrix material formable to fit the shape and size of the cavity in the living body, configured to fill the cavity and support tissue surrounding the cavity, the matrix material having an outer shell containing both biosorbable material and nonabsorbable material, wherein the outer shell is configured to form a skeletal outer shell after a resorption of the biosorbable material; and

a marking material coupled to the matrix material.

12. The implant of claim 11 , wherein the nonabsorbable material of the outer shell comprises monofilament polypropylene fibers.

13. The implant of claim 11 , wherein the resorption of the biosorbable material occurs in situ in the cavity of the living body.

14. The implant of claim 11 , wherein the matrix material is configured to be elastically compressible and self-expanding.

15. The implant of claim 11 , wherein the marking material is a dye, and the matrix material and the marking material are configured such that the marking material leaches into tissue surrounding the cavity from the matrix material.

16. The implant of claim 11 , the marking material being contained within the matrix material.

17. The implant of claim 16 , wherein the marking material includes at least one radiographic marker.

18. The implant of claim 11 , comprising at least one substance selected from the group consisting of medicinal substances, therapeutic substances, and diagnostic substances.

19. The implant of claim 11 , comprising at least one substance selected from the group consisting of radiation materials, antibiotics, chemotherapies, cancer therapeutics, hemostatic materials, and hormone therapeutics.

Continuity (11)
Continuation 13426061 · Mar 21, 2012
Continuation 12965405 · Dec 10, 2010
Continuation 12589413 · Oct 23, 2009
Division 11108785 · Apr 19, 2005
Continuation In Part 10627718 · Jul 28, 2003
Division 09828806 · Apr 10, 2001
Continuation In Part 09169351 · Oct 9, 1998
Provisional Application 60061588 · Oct 10, 1997
Provisional Application 60077639 · Mar 11, 1998
Provisional Application 60091306 · Jun 30, 1998
Related Publication 20140142696A1 · May 22, 2014